SCHEMBL1390362

SCHEMBL1390362

CC(C)CC(CC(=O)c1ccc(=O)n(C)c1)c1ccc(Br)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.38
KMT2A Q03164 3/20 0.37
CTSB P07858 1/20 0.34
POLB P06746 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 2/20 0.33
CTSK P43235 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
ALOX12 P18054 2/20 0.33
HSD17B10 Q99714 2/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
GSK3B P49841 1/20 0.33
OPRM1 P35372 1/20 0.32
GPBAR1 Q8TDU6 1/20 0.32
PKM P14618 1/20 0.32
HTT P42858 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390373 0.85 SLC6A2 (0.41) BRD4KMT2APOLBL3MBTL1MEN1
SCHEMBL369368 0.85 GPBAR1 (0.41) BRD4CTSBGPBAR1HTT
SCHEMBL369127 0.85 GPBAR1 (0.41) BRD4CTSBGPBAR1HTT
SCHEMBL369128 0.85 GPBAR1 (0.41) BRD4CTSBGPBAR1HTT
SCHEMBL1390238 0.84 KMT2A (0.36) BRD4KMT2APOLBL3MBTL1MEN1
SCHEMBL1390316 0.83 SLC6A2 (0.38) BRD4KMT2APOLBL3MBTL1MEN1
SCHEMBL1390106 0.81 BRD4 (0.35) BRD4KMT2APOLBL3MBTL1MEN1
SCHEMBL370259 0.79 KMT2A (0.40) BRD4KMT2APOLBL3MBTL1MEN1
SCHEMBL369733 0.77 GPBAR1 (0.54) BRD4KMT2AMEN1ALDH1A1MAPT
SCHEMBL369140 0.77 GPBAR1 (0.54) BRD4KMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 BRD4 3540/4885KMT2A 3981/4885CTSB 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.